(IN BRIEF) Novo Nordisk has announced separate research collaborations with Omega Therapeutics and Cellarity Inc. to explore innovative treatment approaches for obesity and MASH (Metabolic Associated Fatty Liver Disease). The collaboration with Omega aims to develop an epigenomic controller to … Read the full press release
Posted in Business, Denmark, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Cellarity Inc., Fabrice Chouraqui, innovative, Mahesh Karande, Marcus Schindler, MASH (Metabolic Associated Fatty Liver Disease), Novo Nordisk, Obesity, Omega Therapeutics, partnership, Paul Biondi, sustainability, treatments, USA
(IN BRIEF) Researchers at the University of Warwick, in collaboration with other institutions and charities, are leading a groundbreaking initiative to improve the diagnosis and treatment of Obstructive Sleep Apnoea (OSA). OSA often goes undiagnosed, leading to sleep disturbances and … Read the full press release
(IN BRIEF) QIAGEN, a leading provider of molecular diagnostics and life sciences solutions, is significantly expanding its operations in the Middle East region. In early 2024, the company will open its regional headquarters in Riyadh, Saudi Arabia, to strengthen its … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged Middle East, Oman, partnership, QIAGEN, Riyadh HQ, Saudi Ministry of Health, Simona Grandits, sustainability, TB Screening Initiative
(IN BRIEF) The Nordic Investment Bank (NIB) has entered into a 20-year EUR 70 million loan agreement with the Wellbeing Services County (WSC) of North Savo, Finland, to fund the expansion and renovation of the “Uusi Sydän” central hospital and … Read the full press release
(IN BRIEF) AstraZeneca has announced its definitive agreement to acquire Gracell Biotechnologies Inc. (NASDAQ: GRCL), a global biopharmaceutical company specializing in cell therapies for cancer and autoimmune diseases. This strategic move aims to bolster AstraZeneca’s presence in the field of … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged acquisition, Adrian Kemp, AstraZeneca, cell therapy, Dr. William Cao, Gracell Biotechnologies, Gracell's GC012F, partnership, Susan Galbraith, sustainability
(IN BRIEF) The European Investment Bank (EIB) has signed a €12.5 million venture debt agreement with Swedish medical company BrainCool AB, specializing in medical cooling solutions. BrainCool is pioneering body cooling technologies that have the potential to revolutionize care standards … Read the full press release
Posted in Banks, Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Sweden, Technology
Tagged BrainCool AB, Cooling Technologies, EIB, innovative, Martin Waleij, partnership, sustainability, Thomas Östros
(IN BRIEF) Sanofi has announced the discontinuation of the global clinical development program for tusamitamab ravtansine, following an interim analysis of the Phase 3 CARMEN-LC03 trial. The trial assessed tusamitamab ravtansine as a monotherapy in previously treated metastatic non-squamous non-small … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech, Science
Tagged Dietmar Berger, NSCLC, Sanofi, Tusamitamab Ravtansine
(IN BRIEF) BioNTech and Duality Biologics have received Breakthrough Therapy designation from the FDA for their antibody-drug conjugate (ADC) candidate, BNT323/DB-1303. The designation is for the treatment of advanced endometrial cancer in patients who have progressed following immune checkpoint inhibitor … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech, Technology
Tagged advanced endometrial cancer, antibody-drug conjugate, BioNTech SE, BNT323, Breakthrough Therapy, DB-1303, Duality Biologics, DualityBio, endometrial cancer, FDA, HER2, Human Epidermal Growth Factor Receptor 2, Prof. Özlem Türeci M.D., uterine cancer, Vivian Gu M.D.
(IN BRIEF) Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) under Priority Review. The sBLA is for the reduction of allergic reactions, including anaphylaxis, caused by … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged adults, allergic reactions, CHILDREN, FDA approval, Levi Garraway, Multiple Foods, Reducing, Roche, Xolair®
(IN BRIEF) The Office for National Statistics (ONS) has released data on suicides in England and Wales for the year 2022, highlighting the persistence of suicide rates that have remained largely unchanged for over two decades. In response to the … Read the full press release
Posted in Business, Government, Healthcare, Industrial, Management, News, Non Profit, Society, United Kingdom
Tagged England, Jacqui Morrissey, ONS, partnership, Samaritans, Suicide Rates, Urgent Action, Wales
(IN BRIEF) Almirall S.A., a global pharmaceutical company specializing in medical dermatology, has confirmed its involvement in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, taking place from January 8th to 11th, 2024. Carlos Gallardo, Chairman and CEO … Read the full press release
Posted in Business, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Spain, Technology
Tagged 42nd Annual J.P. Morgan Healthcare Conference, Almirall, Carlos Gallardo, San Francisco
(IN BRIEF) Researchers at Eindhoven University of Technology (TU/e) have made a significant breakthrough in the early detection of esophageal cancer through the use of artificial intelligence (AI). Over a decade of research led by Fons van der Sommen has … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Early Esophageal Cancer Detection, endoscopy, Erik Schoon, Fons van der Sommen, Jacques Bergman, Peter de With, researchers, TU/e, wellness
(IN BRIEF) The European grant scheme Interreg has awarded over €1.2 million to the University of Twente (UT) research project BRIDGE, which is dedicated to cross-border healthcare cooperation. Scheduled to commence in spring 2024, BRIDGE aims to map ongoing initiatives, … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Science
Tagged BRIDGE Project, Caroline Fischer, Gréanne Leeftink, Healthcare Cooperation, Interreg, Le Anh Long, Manon Bruens, Oliver Treib, University of Twente, Vincent Hofbauer, Vittoria Chimisso
(IN BRIEF) Researchers at PSI have made a surprising discovery that could expand the medical applications of botulinum toxin A1, commonly known as Botox. They have developed antibody-like proteins called DARPins that unexpectedly accelerate the toxin’s impact on nerve signal … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, News, Science, Switzerland, Technology
Tagged Botox, DARPins, Medical Treatments PSI, Oneda Leka, proteins
(IN BRIEF) BioNTech has achieved a significant milestone in expanding mRNA vaccine manufacturing in Africa with the inauguration of its Kigali site, which includes the first manufacturing unit known as BioNTainer. This move is part of BioNTech’s broader efforts to … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Africa, BioNTainer, BioNTech, Dr. Jean Kaseya, H.E. Macky Sall, H.E. Paul Kagame, H.E. Ursula von der Leyen, Hon. Annalena Baerbock, Moussa Faki Mahamat, mRNA Vaccine, Prof. Ugur Sahin, Rwanda, Sierk Poetting, vaccine
(IN BRIEF) EQT X fund has announced its acquisition of Zeus Company Inc., a pioneer in the design and production of fluoropolymer tubing for medical devices and select industrial applications. The acquisition aims to support Zeus’ continued growth as a … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, Sweden, Technology
Tagged acquisition, EQT, Eric Liu, Ethan Waxman, John Groetelaars, medical device, partnership, Steve Peterson, Zeus Company
(IN BRIEF) GSK plc has announced positive results from Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial, evaluating the use of Jemperli (dostarlimab) in combination with standard chemotherapy and as maintenance therapy for patients with primary advanced or recurrent endometrial … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged chomotherapy, dostarlimab, Endometrial Cancer Trial, GSK, Hesham Abdullah, RUBY, Zejula
(IN BRIEF) A study led by researchers from the University of Cambridge and King’s College London highlights the importance of valuing patients’ “lived experiences” in the diagnostic process. The research, involving over 1,000 patients and clinicians, revealed that clinicians often … Read the full press release
Posted in Business, Education, Healthcare, Industrial, Management, News, Science, Technology, United Kingdom
Tagged 'Lived Experiences', Diagnosis Process, Dr Tom Pollak, King’s College London, Melanie Sloan, neuropsychiatric lupus, partnership, Recognition of Patients', study, Sue Farrington, sustainability, University of Cambridge
(IN BRIEF) The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMAs) have jointly released a comprehensive Artificial Intelligence (AI) workplan outlining their collaborative strategy through 2028. This initiative aims to maximize the benefits of AI for stakeholders … Read the full press release
Posted in Artificial Intelligence (AI), Business, Environment, European Union, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged 2028 Workplan, artificial-intelligence, EMA, HMAs, Medicines Regulation, partnership, sustainability
(IN BRIEF) In a significant development for Africa’s pharmaceutical sector, the African Pharmaceutical Technology Foundation and the Rwandan Government have signed a host country agreement, paving the way for the Foundation’s operationalization. The Foundation has also forged a memorandum of … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Technology
Tagged Africa, African Development Bank, African Pharmaceutical Industry, African Pharmaceutical Technology Foundation, Dr Akinwumi Adesina, Dr Bärbel Kofler, Dr Ngozi Okonjo-Iweala, Dr Tedros Adhanom Ghebreyesus, Dr Vincent Biruta, EIB, Gelsomina Vigliotti, partnership, Professor Padmashree Gehl Sampath, sustainability
(IN BRIEF) Roche (SIX: RO, ROG; OTCQX: RHHBY) has once again secured its position as one of the leading sustainable companies in the Pharmaceuticals sector within the Dow Jones Sustainability Indices (DJSI). In the latest rankings, Roche secured the third … Read the full press release
(IN BRIEF) Novadip, a Belgian biotech company, has secured €18 million in venture debt financing from the European Investment Bank (EIB) with support from the European Union’s InvestEU initiative. The funds will be utilized for clinical trials of NVD-003, an … Read the full press release
(IN BRIEF) The European Investment Bank (EIB) has signed a €70 million loan agreement with Stichting Vivium Zorggroep to support the organization’s investment plans until 2030. Vivium plans to modernize its building management approach, adapt its facilities for new care … Read the full press release
Posted in Banks, Business, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, Netherlands, News, Real Estate
Tagged Elderly Care Facilities, Erwin Melger, European Investment Bank, Kris Peeters, Marco Wisse, Netherland, partnership, sustainability, Vivium Zorggroep
(IN BRIEF) Roche, a global pharmaceutical company, has shared compelling data from its CD20xCD3 T-cell engaging bispecific antibody program during the 65th American Society of Hematology (ASH) Annual Meeting & Exposition held in December 2023. The data includes extended follow-up … Read the full press release
(IN BRIEF) In a significant development, GSK plc has received marketing authorization from the European Commission (EC) for Jemperli (dostarlimab) in combination with carboplatin-paclitaxel chemotherapy as a treatment option for adult patients suffering from mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) … Read the full press release
(IN BRIEF) In the Phase 3 IsKia trial presented at the American Society of Hematology (ASH) Annual Meeting, Sarclisa® (isatuximab) combined with carfilzomib, lenalidomide, and dexamethasone (KRd) demonstrated a significant improvement in achieving minimal residual disease (MRD) negativity among newly … Read the full press release
Posted in Business, Education, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged carfilzomib, Combination Therapy, dexamethasone, Francesca Gay, lenalidomide, Myeloma, Peter C. Adamson, Phase 3 Trial, Remission Rates, Sanofi, Sarclisa
(IN BRIEF) Roche has released positive long-term follow-up data from the Phase III KATHERINE study, evaluating Kadcyla® (trastuzumab emtansine) as adjuvant therapy for people with HER2-positive early-stage breast cancer (eBC) who have residual invasive disease following neoadjuvant treatment. The study … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Science, Switzerland, Technology
Tagged breast cancer, HER2-Positive, Kadcyla, Levi Garraway, Long-Term Survival, Phase III KATHERINE, Prof. Dr. Sibylle Loibl, Roche
(IN BRIEF) Roche has announced promising results from the Phase III INAVO120 study, which evaluated inavolisib in combination with palbociclib (Ibrance®) and fulvestrant as a first-line treatment for individuals with PIK3CA-mutated, hormone receptor (HR)-positive, HER2-negative, endocrine-resistant, locally advanced, or metastatic … Read the full press release
(IN BRIEF) The COMBINE-CT consortium, led by Philips and supported by a €6.5 million grant from the Innovative Health Initiative (IHI), is dedicated to improving the diagnosis and treatment of coronary artery disease (CAD). CAD, characterized by the accumulation of … Read the full press release
(IN BRIEF) Sanofi is showcasing its ambitious pipeline transformation strategy, which includes a record 12 potential blockbuster opportunities currently under clinical evaluation. Among these, there are nine innovative medicines and vaccines with peak sales potential ranging from €2 to €5 … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged Houman Ashrafian, Immunology Industry, Paul Hudson, Sanofi
(IN BRIEF) The Phase 3 IMROZ trial, assessing the use of Sarclisa® (isatuximab) in combination with standard-of-care bortezomib, lenalidomide, and dexamethasone (VRd), has achieved its primary efficacy endpoint at a planned interim analysis. The trial demonstrated a statistically significant improvement … Read the full press release
Posted in Business, France, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged Dietmar Berger, IMROZ trial, Multiple Myeloma Patients, Sanofi, Sarclisa, Thierry Facon
(IN BRIEF) The North Cumbria Integrated Care NHS Foundation Trust, GRAHAM, and CCL Solutions have been honored with the ICW Collaborative Working Award for their successful collaboration in delivering critical healthcare construction projects. This partnership, which implemented ISO44001 collaborative practices, … Read the full press release
Posted in Awards, Business, Construction, Environment, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, United Kingdom
Tagged Award, CCL Solutions, GRAHAM, Healthcare Projects, Keith Hayes, North Cumbria NHS Trust, partnership, Stephen Prince, sustainability
(IN BRIEF) Roche, a leading pharmaceutical company, has announced its definitive merger agreement to acquire Carmot Therapeutics, a privately owned US-based company specializing in obesity treatment and related metabolic diseases. The acquisition includes Carmot’s portfolio of clinical stage subcutaneous and … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged acquisition, Carmot Therapeutics, CT-388, Levi Garraway, metabolic disease, Obesity Treatment, Roche, Thomas Schinecker, USA
(IN BRIEF) Professor Laura Bojke, an esteemed expert in health economics from the University of York’s Centre for Health Economics, has been named the Inaugural Chair of the World Health Organization (WHO) Advisory Group on Economics for Environment, Climate Change, … Read the full press release
(IN BRIEF) Sanofi’s Consumer Healthcare business unit (CHC) has introduced the Shared Care Collective, an advisory board consisting of experts from various fields, both internal and external, to bolster sustainability efforts within the CHC business. This initiative aims to foster … Read the full press release
(IN BRIEF) Dr. Edward Emmott, a researcher at the University of Liverpool, has received the prestigious Wellcome Trust Career Development Award, a highly competitive fellowship. This funding will support Dr. Emmott’s crucial research efforts aimed at gaining a deeper understanding … Read the full press release
(IN BRIEF) Despite technological advancements, the long-term survival of transplanted kidneys has seen little improvement in the past two decades, with approximately 40% of transplanted kidneys being rejected within ten years. In response, the Nierstichting and NWO are collaborating in … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged health, Kidney Transplant Survival, Nierstichting, NWO, partnership, sustainability
(IN BRIEF) A groundbreaking miniaturized spectroscopy module has been created through a partnership between trinamiX, LUMILEDS, and VIAVI Solutions. Designed to run on Qualcomm Technologies’ Snapdragon® 8 Gen 3 reference design, the module brings near-infrared (NIR) spectroscopy to smartphones. This … Read the full press release
Posted in Business, Electronics & Machinery, Germany, Healthcare, Technology, Telecom
Tagged 2023 Qualcomm Snapdragon Summit, Adam Scheer, biomarkers, detector, filter manufacturers, health indicators, LED light sources, light shaping optics, light source, LUMILEDS, Near-infrared spectroscopy, NIR spectroscopy modules, Noman Rangwala, optical filters, Qualcomm Technologies, smartphones, Snapdragon Summit 2023, Snapdragon® 8 Gen 3, spectrometers, trinamiX, VIAVI Solutions, Wilfried Hermes
(IN BRIEF) AstraZeneca is set to unveil promising data at the 65th American Society of Hematology (ASH) Annual Meeting, highlighting its expanding hematology pipeline and the enduring effectiveness of Calquence in treating chronic lymphocytic leukemia (CLL). The presentation includes six-year … Read the full press release
(IN BRIEF) Roche has unveiled Elecsys® HBeAg quant, a new immunoassay designed to detect the presence and quantity of the hepatitis B e antigen (HBeAg) in human serum and plasma. This diagnostic tool simplifies the process for both clinicians and … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged diagnosis, Elecsys®, HBeAg Quant Test, Hepatitis B, Matt Sause, monitoring, Roche
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
